{"organizations": [], "uuid": "4ec69cb691f2ace3287082126129ea6c9af8ca10", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-partner-therapeutics-acquires-leuk/brief-partner-therapeutics-acquires-leukine-from-sanofi-idUSASB0C3GJ", "country": "US", "domain_rank": 408, "title": "BRIEF-Partner Therapeutics Acquires Leukine From Sanofi", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-01T14:04:00.000+02:00", "replies_count": 0, "uuid": "4ec69cb691f2ace3287082126129ea6c9af8ca10"}, "author": "", "url": "https://www.reuters.com/article/brief-partner-therapeutics-acquires-leuk/brief-partner-therapeutics-acquires-leukine-from-sanofi-idUSASB0C3GJ", "ord_in_thread": 0, "title": "BRIEF-Partner Therapeutics Acquires Leukine From Sanofi", "locations": [], "entities": {"persons": [], "locations": [{"name": "washington", "sentiment": "none"}, {"name": "lynnwood", "sentiment": "none"}], "organizations": [{"name": "brief-partner therapeutics acquires leukine from sanofi reuters", "sentiment": "negative"}, {"name": "sanofi", "sentiment": "negative"}, {"name": "sanofi sa", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 05 PM / in 10 minutes BRIEF-Partner Therapeutics Acquires Leukine From Sanofi Reuters Staff \nFeb 1 (Reuters) - Sanofi Sa: * PARTNER THERAPEUTICS (PTX) ACQUIRES LEUKINEÂ® FROM SANOFI \n* PARTNER THERAPEUTICS INC - HAS ACQUIRED GLOBAL RIGHTS TO DEVELOP, MANUFACTURE, AND COMMERCIALIZE LEUKINE (SARGRAMOSTIM) FROM SANOFI \n* PARTNER THERAPEUTICS - IN CONNECTION WITH ACQUISITION OF LEUKINE, PTX WILL ALSO ACQUIRE A DEDICATED MANUFACTURING FACILITY IN LYNNWOOD, WASHINGTON Source text for Eikon:  ", "external_links": [], "published": "2018-02-01T14:04:00.000+02:00", "crawled": "2018-02-01T14:18:14.038+02:00", "highlightTitle": ""}